Is It Scientifically Possible To ‘Cure” Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?

Author unknown

Open source

DOI
10.31080/asne.2025.08.0815
Published
2025-05-01
Container
Acta Scientific Neurology
Publisher
Acta Scientific Publications Pvt. Ltd.
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31080/asne.2025.08.0815,
  title = {Is It Scientifically Possible To ‘Cure” Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?},
  year = {2025},
  journal = {Acta Scientific Neurology},
  doi = {10.31080/asne.2025.08.0815},
  url = {https://doi.org/10.31080/asne.2025.08.0815}
}

RIS

TY  - JOUR
TI  - Is It Scientifically Possible To ‘Cure” Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?
PY  - 2025
JO  - Acta Scientific Neurology
DO  - 10.31080/asne.2025.08.0815
UR  - https://doi.org/10.31080/asne.2025.08.0815
ER  - 

APA

Is It Scientifically Possible To ‘Cure” Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?. (2025). Acta Scientific Neurology. https://doi.org/10.31080/asne.2025.08.0815

Source records